1. Hesse A, Brandle E, Wilbert D, Kohrmann KU, Alken P (2003) Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 vs. 2000. Eur Urol 44(6):709–713. https://doi.org/10.1016/s0302-2838(03)00415-9
2. Zhe M, Hang Z (2017) Nephrolithiasis as a risk factor of chronic kidney disease: a meta-analysis of cohort studies with 4,770,691 participants. Urolithiasis 45(5):441–448. https://doi.org/10.1007/s00240-016-0938-x
3. Türk CN, Petrik A, Seitz C, Skolarikos A, Thomas K (2020) EAU Guidelines 2020: Urolithiasis. EAU Guidelines. Edn. presented at the EAU Annual Congress Amsterdam 2020. EAU Guidelines Office, Arnhem, The Netherlands. http://uroweb.org/guidelines/compilations-of-all-guidelines/. Zugegriffen: 02.01.2021
4. Schregel C, John H, Randazzo M, Keller I (2017) Influence of acetylsalicylic acid and low-molecular weight heparins on the formation of renal hematoma after shock wave lithotripsy. World J Urol 35(12):1939–1946. https://doi.org/10.1007/s00345-017-2070-0
5. Seitz CB, Bader M, Berg W, Knoll T, Neisius A, Netsch C, Schönthaler M, Siener R, Stein R, Straub M, Strohmaier W, Türk C (2018) S2k-Leitlinie zur Diagnostik, Therapie und Metaphylaxe der Urolithiasis – Aktualisierung 2018